Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Similar documents
Analyses on Cancer Incidence and Mortality in Huai an Area, China, 2010

Incidence and mortality of laryngeal cancer in China, 2011

CKD Prevention Program Protocol

Annual report on status of cancer in China, 2011

Zhao Y Y et al. Ann Intern Med 2012;156:

The updated incidences and mortalities of major cancers in China, 2011

Estimated cancer incidence and mortality in Hebei province, 2012

Cancer incidence and mortality in China in 2013: an analysis based on urbanization level

The improved cure fraction for esophageal cancer in Linzhou city

Chapter 10: Dialysis Providers

USRDS UNITED STATES RENAL DATA SYSTEM

Report of China s innovation increase and research growth in radiation oncology

Ying-Ping Sun, Wen-Jun Yang, Su-Hua Li, Yuan-yuan Han, and Jian Liu

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Nephrology Research Output in Iran in a Decade

Findings- The sample contained participants with a mean age of 55 6 years (SD 9 7), 59 5% of whom were women. 44 7% (95% CI ) of

Chapter 2: Identification and Care of Patients With CKD

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

Chapter 2: Identification and Care of Patients with CKD

An epidemic of renal failure among Australian Aboriginals

Association between multiple comorbidities and self-rated health status in middle-aged and elderly Chinese: the China Kadoorie Biobank study

Chapter 3: Morbidity and Mortality in Patients with CKD

Cancer Incidence and Mortality in China, 2007

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

Long-term outcomes in nondiabetic chronic kidney disease

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003

Application of the WHO Growth Reference (2007) to Assess the Nutritional Status of Children in China

Annual report on status of cancer in China, 2010

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

AVINASH CHANDRA, MD. September 16 th, Business Address: Buffalo Neuroimaging Analysis Center

End stage renal disease (ESRD) is a common and. Incidence of end stage renal disease on renal replacement therapy in Nepal ( ) Audit

Dialysis and Transplantation Audit

162 Biomed Environ Sci, 2014; 27(3):

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

Meeting the Guidelines for End-of-Life Care

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

2018 ASIAN PACIFIC CONGRESS OF NEPHROLOGY

Chapter 2: Identification and Care of Patients With CKD

Changing Epidemiology of End-Stage Renal Disease in Last 10 Years in Iran

The Epidemiologic Transition of Diabetes Mellitus in Taiwan: Implications for Reversal of Female Preponderance from a National Cohort

Introduction. 1. Introduction

Nasopharyngeal carcinoma incidence and mortality in China in 2010

UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE. Advancing Nephrology Around the World

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

United States Renal Data System (USRDS) International Data Collection Form

Original Article Continuity of care for quality of life and clinical outcomes in patients with peritoneal dialysis

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

USRDS UNITED STATES RENAL DATA SYSTEM

Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment

Facts and trends in sexual and reproductive health in Asia and the Pacific

Chapter 6: Healthcare Expenditures for Persons with CKD

Validity of Self-reported Diabetes among Middle Aged and Older Chinese Population: China Health and Retirement Longitudinal Study For peer review only

Chapter 5: Acute Kidney Injury

Do kidney transplantations save money? A study using a before after design and multiple register-based data from Sweden

Global Perspectives in CKD: Opportunities and Challenges to improve outcomes around the world

Chapter IV. Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form

Chapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES

Renal replacement therapy for patients with diabetes mellitus in Hong Kong

290 Biomed Environ Sci, 2016; 29(4):

SHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson

Case Presentation Turki Al-Hussain, MD

Under 5 mortality rate and its contributors in Zhejiang Province of China from 2000 to 2009

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

Disparities in Transplantation Caution: Life is not fair.

STATEMENT OF THE NATIONAL KIDNEY FOUNDATION SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS;

S05-1 Social-economic impact of diabetes in New Zealand

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

causes, all cancers, lung cancer and other chronic diseases in urban Shanghai.

Diabetes management: lessons from around the globe MENA. J. Belkhadir (Morocco)

patient characteriuics Chapter Two introduction 58 increasing complexity of the patient population 60 epo use & anemia in the pre-esrd period 62

Management of End Stage Renal Disease-Bangladesh Perspective

Chapter 7: ESRD among Children, Adolescents, and Young Adults

Huangdao People's Hospital

Supplementary Information. Statins Improve Long Term Patency of Arteriovenous Fistula for

Chronic kidney disease (CKD) has received

BioScience Trends. 2018; 12(5): College of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain

China s Health Reform, Chronic Disease Burden and the Elderly

ETHIOPIA S HOUSEHOLD HEALTH SERVICES UTILIZATION AND EXPENDITURE SURVEY

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Chapter 3: Morbidity and Mortality

Thyroid dysfunction in patients of chronic kidney disease

Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

Epidemiology of Asthma. In Wayne County, Michigan

Chapter 5: Acute Kidney Injury

Epidemiology of Asthma. In the Western Michigan Counties of. Kent, Montcalm, Muskegon, Newaygo, and Ottawa

ACKNOWLEDGEMENTS FOR FURTHER INFORMATION

The Burden of Out-of-Pocket Costs for

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Transcription:

DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian, 1 Jing Xiao, 1 Zhanzheng Zhao, 1 Dahai Yu 1,2 Original Paper 1 Department of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China 2 Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Keele, UK Keywords. China, patient care, peritoneal dialysis, population characteristics Introduction. This study aimed to assess the number and profiles of patients initializing peritoneal dialysis form the Henan Peritoneal Dialysis Registry, a provincial database in central China. Materials and Methods. All patients aged 18 years and greater, initializing peritoneal dialysis within the province during 7 to 14 were included. Demographic characteristics were collected and clinical parameters included the type of renal diagnosis (primary glomerular, secondary glomerular, and others) and recorded major comorbidities in the neural, cardiovascular, respiratory, gastrointestinal, and endocrine systems. Laboratory measurements at treatment including blood urea nitrogen and creatinine were also determined. Differences, as a temporal trend over the period, were analyzed using a nonparametric test for trend across ordered groups. Results. A total of 25 patients were included. The number of patients increased rapidly by 8-fold from 7 (n = ) to 14 (n = 592). Overall, % were 55 years and older, and % were females. Forty-five percent of the patients were diagnosed with primary glomerular disease; %, secondary glomerular disease; and 15%, other kidney diseases. Half of the patients had comorbid conditions in cardiovascular system, followed by conditions in of the endocrine (15%) and neural (5%) systems. Over the study period, trends were in favor of more proportions of younger patients, female patients, and patients with secondary glomerular disease. Conclusions. Peritoneal dialysis care increased rapidly in central region of China, with more younger and female patients over the study period. IJKD 18;12:178-84 www.ijkd.org INTRODUCTION The Chronic kidney disease has become an important public health issue worldwide and the mortality in patients with end-stage renal disease (ESRD) is more than -fold greater than general population worldwide, and even worse in the developing countries. 1 The national survey in China estimated that about 1 million Chinese adults aged more than 18 years had chronic kidney disease, and at some time point of their life, the dialysis might be needed. 2 In China, the population size of patients receiving dialysis increased rapidly over the past 2 decades;, only 41 755 patients were receiving dialysis by 1999, as compared with 2 863 patients by 8, and 258 patients by 12. 3,4 Although the patients 178

receiving hemodialysis incorporates the majority of patients receiving dialysis care, in recent years, peritoneal dialysis (PD) utilization increased even faster, as estimated more than patients by 12. 3 However, more PD facilities and trained nephrologists were located in the coastal regions and the capital of China, and provided PD care mainly to urban population. 5 In the central China, where the majority of its population remained in rural area, the number and profile of patients receiving peritoneal care have not been well known. The new rural cooperative medical insurance scheme in China was introduced in 3 and started to sufficiently cover rural population in Henan province since 8, 6 which facilitated PD as an affordable treatment option for rural patients. Henan is the third largest province in China regarding to the size of population (94 million people; female, 49.5%; China Census ), 7 with % of its population living in rural area, a representative region for the central China. The objective of the current study was to assess the number and profile of the whole provincially corded patients initializing PD care in Henan from 7 to 14. MATERIALS AND METHODS Data Source The Henan Peritoneal Dialysis Registry (HPDR) is operated under the auspices of the Department of Nephrology, the First Affiliated Hospital of Zhengzhou University and provides independent audit and analysis of renal care in Henan, China. Information was prospectively collected electronically from all renal units across Henan province. Data received at HPDR are subjected to algorithm which identifies suspicious values. If suspicious data is caught further verification will be carried out manually by contacting the relevant renal unit, and any correction will be made wherever necessary. The registration officially launched in 7 and in this analysis all patients aged more than 18 years and initializing PD within the province between 7 and 14 were included. The data for hemodialysis was not included in the current study. Measurements Sex and age (grouped into 5 categories of < 35, 35 to 44, 45 to 54, 55 to 64, and 65 years old) and body mass index (BMI, kg/m 2 ) at the first time of PD treatment were collected as demographic characteristics. Clinical parameters included type of diagnosed kidney disease (ie, primary glomerular disease, secondary glomerular disease, other kidney diseases) and recorded major comorbid conditions in neural, cardiovascular, respiratory, gastrointestinal, and endocrine systems. Laboratory measurements were those collected during the episode of PD treatment at clinics using standard methods. Blood urea nitrogen (mmol/l) and creatinine (µmol/l) were included. Ethics and Consent Ethics approval was granted by the Clinical Research Ethics Committee of the First Affiliated Hospital of Zhengzhou University. Written informed consent was obtained from all participants at registration. Statistical Analysis The demographic, clinical, and laboratory characteristics of the patients initializing PD were described as a whole and by each calendar year using standard descriptive statistics. Difference as a temporal trend over the study period (7 to 14) was analyzed by a nonparametric test for trend across ordered groups, an extension of the Wilcoxon rank-sum test. 8 There was missing data on measurements of BMI, blood urea nitrogen, and creatinine. The demographics (age and sex) in patients with complete and incomplete data were compared using the Chi-squared test. The statistical significant level was set at a P value less than.5, two tailed. All statistical analyses were carried out using the Stata (version 14., StataCorp LP, College Station, TX, USA). Graphics were produced using the Microsoft Excel. RESULTS In total, 25 patients were recorded. The number of patients initializing PD increased rapidly from 7 to 12 (an approximate 8-fold increase), and then remained approximately stable during the recent years (Table 1). Collected demographic, clinical, and laboratory parameters in all patients between 7 and 14 are summarized in Table 2. Approximately % of the patients were 55 years old and over, and % were females. Forty-five percent of the patients were diagnosed with primary 179

Table 1. Number of Patients Initializing Peritoneal Dialysis by Calendar Year Number of Patients 7 8 84 9 1 146 11 353 12 549 13 596 14 592 Table 2. Characteristics of All Patients Initialising Peritoneal Dialysis* Characteristic Value Demographic Number of patients 25 Age, y < 35 371 (14.6) 35 to 44 518 (.4) 45 to 54 641 (25.2) 55 to 64 567 (22.3) 65 443 (17.4) Females 1491 (58.7) Body mass index, kg/m 2 23. (21. to 25.) Clinical Diagnosis Primary glomerular disease 1132 (44.6) Secondary glomerular disease 13 (39.9) Other renal disease 395 (15.5) Comorbidity in neural system 1 (5.1) Comorbidity in cardiovascular 12 (49.6) system Comorbidity in respiratory system 61 (2.4) Comorbidity in gastrointestinal (3.9) system Comorbidity in endocrine system 391 (15.4) Laboratory Median blood urea nitrogen, mmol/l 21.9 (17.7 to 26.5) Median serum creatinine, µmol/l 871. (668.1 to 85.) *Values are frequencies (percentage) or median (interquartile range). Body mass index on 1447 patients (57.%); blood urea nitrogen on 14 patients (55.1%); and serum creatinine on 12 patients (55.2%). glomerular disease; %, secondary glomerular disease; and the remaining 15%, as other kidney diseases. Half of the patients had comorbid conditions related to the cardiovascular system, followed by comorbidities in the endocrine (15%) and neural (5%) systems. By calendar year, more proportion of the patients aged less than 35 years old (from 5.7% in 7 to 16.7% in 14) and less proportion aged 65 years and greater (from 28.5% in 7 to 16.2% in 14) were observed, showing a decreasing trend in patients age over the study period (P =.4; Figure 1). In 7, 45.7% of the patients were females, while this increased to 62.2% in 14 (P =.1; Figure 1). No difference was observed in BMI (Figure 1). The percentage of patients diagnosed with different kidney diseases, stratified by calendar year is shown in Figure 2. Except for the data in 7, during the earlier years (8 to 11), there was a higher proportion of patients with a primary glomerular disease compared to the proportion with a secondary glomerular disease. However, the difference became smaller as the time went ahead. In the recent years (12 to 14), primary and secondary glomerular diseases contributed approximately equally (each about %) to the patient population. During all the study years, testing for trend suggested an increased contribution from secondary glomerular disease (P <.1). The record of major comorbid conditions stratified by calendar year is presented in Figure 3. The assessment of levels of blood urea nitrogen and creatinine demonstrated no significant difference over the study period (Figure 4). The age and sex in the patients with complete and incomplete data were shown in Table 3. No significant difference was found in the demographics between the two groups. DISCUSSION To our knowledge, this is the first study that investigated the number and profile of patients initializing PD care in a central region of China where rural residents contribute to the majority of population and during the years when the new rural cooperative medical insurance scheme was introduced. The results show that patients initializing PD increased rapidly from 7 to 14, according to the provincial registration database of Henan. Higher proportion of younger and female patients was observed in the recent years, compared to that in the earlier period. Secondary glomerular disease was shown to become a more important disease for which patients initializing PD treatment over the study period in contrast with primary glomerular disease, despite of the rapidly increasing number of PD care for both diseases. However, the reason behind such changes remains to be investigated. Some laboratory markers measuring kidney 1

Percentage of Patients 7 8 9 11 12 13 14 < 35 y 35-44 y 45-54 y 55-64 y 65 y Body Mass Index, Kg/m 2 Percentage of Patients 7 8 9 11 12 13 14 Female Male 7 8 9 11 12 13 14 Figure 1. Patient demographics (age, sex, and body mass index) by calendar year (7 to 14). 181

Percentage of Patients 7 8 9 11 12 13 14 Primary glomerular disease Secondary glomerular disease Other renal disease Figure 2. Percentage of patients diagnosed with primary glomerular, secondary glomerular, and other renal diseases by calendar year (7 to 14). Percentage of Patients 7 8 9 11 12 13 14 Neuro Cardiovascular Respiratory Gastrointestinal Endocrine Figure 3. Percentage of patients identified with comorbid conditions in major systems by calendar year (7 to 14). function, which included blood urea nitrogen and creatinine, suggest that patients kidney function at the baseline of receiving PD care did not differ over the study period. Although no trend data on the prevalence of chronic kidney disease over the relevant years was reported in China, several studies in other countries showed a stable trend. 9, According to a population-based screening study on residents over years old in Henan province in, approximately.5% of the subjects had an indicator of kidney damage. 12 There was therefore a large size of potential patients who needed dialysis in Henan. In the current study, an 8-fold increase in the number of patients starting PD care was seen from 7 to 14. The beginning point coincided with the start of sufficient coverage of medical insurance under the new rural cooperative scheme, suggesting this increasing trend may be driven by financial affordability rather than disease burden. Improved family income might also contribute to the increasing trend. However, no information was available from HPDR. It was reported that 16% of Chinese patients withdrew from dialysis due to financial stress in 1999. 3 Our study implied somehow there might be some proportion of patients 182

Blood Urea Nitrogen, mmol/l 7 8 9 11 12 13 14 Serum Creatinine, μmol/l 7 8 9 11 12 13 14 Figure 4. Laboratory measurement (blood urea nitrogen and creatinine) of patients initializing peritoneal dialysis by calendar year (7 to 14). Table 3. Age and Sex Distributions in Patients With Complete and Incomplete Data Characteristics Patients With Complete Data (n = 1387) Patients With Incomplete Data (n = 1153) Age, y < 35 219 (15.8) 152 (13.2) 35 to 44 281 (.3) 237 (.6) 45 to 54 355 (25.6) 286 (24.8) 55 to 64 3 (21.9) 264 (22.9) 65 229 (16.5) 214 (18.6) >.5 Females 811 (58.5) 6 (59.) >.5 decided not to receive dialysis treatment due to financial burden. However, data for hemodialysis was not included in the current study. P Long-term dialysis is life-saving for patients with end stage renal disease. 12 Those residing within the east and large city centers have greater access to affordable healthcare, while those living within the remote areas tend to be less able to afford or access chronic dialysis or healthcare. Although it has been largely improved during the last decade, greater effort is required to support to deliver sustainable PD care to uremic patients living in rural China. There were several limitations in our study. First, although the majority of population in Henan is rural residents, the actual background (ie, rural or urban) of patients in the current study was not assessed. Second, residents in Henan may receive 183

PD care in other provinces. However, due to the restricted term on the medical insurance scheme (ie, insurance coverage only applies to the cost spent within the province), only a very small proportion if not none is expected. Third, although the clinical measurements were validated by the algorithm, the report of comorbid condition from renal clinics was not further validated by the registration center. Fourth, it cannot be ruled out that the quality of recording in HPDR went better along with the time, so the data might be biased by this possibility. Fifth, there was missing information on clinical measurements such as BMI and urea nitrogen. As the demographical characteristics were comparable between the patients with and without complete records, the findings would less likely to be removed by missing information. Sixth, although the current study used data from a large province in China, the observation was based on the relatively small number of patients each year specifically in the earlier years. CONCLUSIONS Peritoneal dialysis care increased rapidly in central region of China recently, where rural residents constituted the majority of population. ACKNOWLEDGMENTS The authors thank the First Affiliated Hospital and the HPDR that approved this study and provided data. FINANCIAL SUPPORT This research was funded by infrastructure support funds from the First Affiliated Hospital, Zhengzhou University. The funders did not influence the conduct of the study, analysis or interpretation of the data, the writing of this report or the decision to publish. CONFLICT OF INTEREST None declared. REFERENCES 1. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32:853-6. 2. Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 12;379:815-22. 3. Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol. 1;17:77-8. 4. Zuo L, Wang M. Chinese Association of Blood Purification Management of Chinese Hospital Association. Current burden of ESRD in China estimated to be increasing fast in the near future. Clin Nephrol. ;73:S1-3. 5. Zheng CH, Chen HP, Wang YU, Li LS. Epidemiologic analysis of renal disease in China based on 22 years of renal biopsy. Chin J Nephrol Dial Transplant. 1;9:3-8. 6. Guo N, Iversen T, Lu M, Wang J, Shi L. Does the new cooperative medical scheme reduce inequality in catastrophic health expenditure in rural China? BMC Health Serv Res. 16;16:653. 7. China Census. National Bureau of Statistics of the People s Republic of China [Accessed 21 September 17]. Available from: http://www.stats.gov.cn/tjsj/tjgb/ rkpcgb/qgrkpcgb/14/t1429_328.html 8. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-. 9. Hsu RK, Powe NR. Recent trends in the prevalence of chronic kidney disease: not the same old song. Curr Opin Nephrol Hypertrtens. 17;26:187-96.. Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 16;165:473-81. 11. Shan Y, Zhang Q, Liu Z, Hu X, Liu D. Prevalence and risk factors associated with chronic kidney disease in adults over years: a population study from Central China. Nephrology (Carlton). ;15:354-61. 12. Szeto CC, Kwan BC, Chow KM, et al. Life expectancy of Chinese patients with chronic kidney disease without dialysis. Nephrology (Carlton). 11;16:715-9. Correspondence to: Zhanzheng Zhao, PhD Department of Nephrology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 52, China Tel: +86 371 6629 5963 Fax: +86 371 6698 8753 E-mail: zhanzhengzhao@zzu.edu.cn Dahai Yu, PhD Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Keele ST5 5BG, UK Tel:+44 1782 734891 Fax:+44 1782 734719 E-mail: d.yu@keele.ac.uk Xiaoxue Zhang and Ying Chen contributed equally to this manuscript as first authors. Received September 17 Revised December 17 Accepted December 17 184